Sorin Group perfusion system – Heater Cooler 3T devices 에 대한 현장 안전성 서한

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI)에 따르면, 해당 현장 안전성 서한 는 Slovenia 에서 LivaNova Deutschland GmbH 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

현장 안전성 서한은 의료기기 제조사 또는 제조사 대리인이 시중에 유통되고 있는 자사 의료기기 제품에 대하여 취할 수 있는 조치를 알리는 소통방식입니다. 주요 대상층은 보건의료업계 종사자와 의료기기 사용자들입니다. 여기에는 회수(recall) 조치와 경고도 포함될 수 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Field Safety Notice
  • 날짜
    2017-05-03
  • 사례 국가
  • 사례 출처
    AMPMDRS
  • 비고 / 경고
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • 데이터 추가 비고
  • 원인
    Over the past two years, livanova and the broader cardiac surgery community has learned a great deal about a newly-identified infection risk to open-heart surgery patients called nontuberculous mycobacterium (“ntm”). ntm are widespread in nature and are commonly found in the soil, natural water, drinking water distribution systems, and household and building plumbing, especially in recirculating hot water systems in hospitals and apartment buildings. ntm are typically not harmful, but in rare cases may cause infections in very ill patients or individuals with compromised immune systems. in june 2015, sorin group deutschland gmbh, now livanova deutschland gmbh, issued a field safety notice regarding “cardiac surgery mycobacterium risks; disinfection and cleaning of sorin heater cooler devices” (attachment 1) to mitigate a potential risk of patient infection by non- tuberculous mycobacteria released from the heater-cooler 3t. in october 2016, following several communications related to nontuberculous mycobacterial (ntm) infections associated with the use of heater-cooler devices issued by the united states centers for disease control and prevention (cdc) and food and drug administration (fda), livanova distributed a second fsn (attachment 2) reiterating and supplementing some of the recommendations contained in the june 2015 fsn. additionally, the october 2016 communication indicated that, livanova continued to develop solutions that further mitigate the potential risk of m. chimaera contamination, working closely with the regulatory authorities to obtain approval. .

Device

Manufacturer